LARIAM Side Effects

5832404-4 | Anxiety, Arthralgia, Asthma, Back Disorder, Bone Disorder, Confusional State, Depression, Dyspepsia, Dyspnoea
on Jul 31, 2008 Male patient from UNITED STATES , 46 years of age, weighting 220.0 lb, was diagnosed with malaria (What is malaria?) and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), arthralgia, asthma (What is asthma?), back disorder, bone disorder, confusional state, depression (What is depression?), dyspepsia, dyspnoea. Lariam dosage: 60 One Per Day Buccal. Patient was hospitalized and became disabled.

5823376-7 | Affect Lability, Anxiety, Arrhythmia, Compulsions, Depression, Heart Rate Irregular, Irritability, Job Dissatisfaction, Muscle Twitching
Patient was taking Lariam (View Usage). Patient had the following side effects: affect lability, anxiety (What is anxiety?), arrhythmia (What is arrhythmia?), compulsions, depression (What is depression?), heart rate irregular, irritability, job dissatisfaction, muscle twitching on Jul 14, 2008 from GERMANY Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: .

5821277-1 | Activities Of Daily Living Impaired, Anxiety, Crying, Depression, Disorientation, Hallucination, Insomnia
Adverse event was reported on Jul 22, 2008 by a Male patient taking Lariam (View Usage) (Dosage: Three Pills) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 22 years of age, weighting 165.0 lb, After Lariam was administered, patient had the following side effects: activities of daily living impaired, anxiety (What is anxiety?), crying, depression (What is depression?), disorientation, hallucination, insomnia.

5810454-1 | Affect Lability, Anxiety, Cardiovascular Disorder, Compulsions, Depression, Heart Rate Irregular, Irritability, Muscle Twitching, Nervous System Disorder
on Jul 14, 2008 Male patient from GERMANY , weighting 165.3 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: affect lability, anxiety (What is anxiety?), cardiovascular disorder, compulsions, depression (What is depression?), heart rate irregular, irritability, muscle twitching, nervous system disorder. Lariam dosage: .


5809717-5 | Anxiety, Depression, Malaise, Muscle Twitching, Nerve Injury, Pain
on Jul 14, 2008 Male patient from UNITED KINGDOM , 25 years of age, weighting 191.8 lb, was treated with Lariam (View Usage). Patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), malaise, muscle twitching, nerve injury, pain (What is pain?). Lariam dosage: 1 Tablet Weekly Po.

5794845-3 | Hallucination, Visual, Incoherent, Nightmare, Psychotic Disorder
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: hallucination, visual, incoherent, nightmare, psychotic disorder (What is psychotic disorder?) on Jun 16, 2008 from SWEDEN Additional patient health information: Female patient , 27 years of age, was diagnosed with malaria prophylaxis and. Lariam dosage: . During the same period patient was treated with MALARONE (View Malarone Review and Malarone Label ). Patient was hospitalized.

5781458-2 | Completed Suicide, Delusion
Adverse event was reported on Jun 12, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) . Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: completed suicide, delusion.

5778564-5 | Aggression, Anger, Anxiety, Attention Deficit/hyperactivity Disorder, Brain Injury, Depression, Fatigue, Insomnia, Mood Swings
on Jun 18, 2008 Male patient from UNITED STATES , 21 years of age, weighting 160.0 lb, was treated with Lariam (View Usage). Patient had the following side effects: aggression, anger, anxiety (What is anxiety?), attention deficit/hyperactivity disorder, brain injury, depression (What is depression?), fatigue, insomnia, mood swings. Lariam dosage: 1 Pill Once Po.

5776506-X | Mental Disorder, Panic Attack, Suicidal Ideation
on Jun 17, 2008 Female patient from UNITED STATES , 46 years of age, weighting 135.0 lb, was diagnosed with foreign travel and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: mental disorder, panic attack, suicidal ideation. Lariam dosage: One Tablet Weekly. Patient was hospitalized.

5773271-7 | Confusional State, Depression, Hallucination, Mania, Psychotic Disorder, Suicidal Ideation, Thinking Abnormal
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, depression (What is depression?), hallucination, mania, psychotic disorder (What is psychotic disorder?), suicidal ideation, thinking abnormal on Jun 13, 2008 from UNITED STATES Additional patient health information: Male patient , 21 years of age, weighting 210.0 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: Weekly Po.

5766736-5 | Completed Suicide, Delusion
Adverse event was reported on Jun 03, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) . Location: UNITED STATES , 48 years of age, Patient had the following side effects: completed suicide, delusion.

5765673-X | Asthenia, Depression, Disorientation, Fatigue, Nausea, Overdose, Paraesthesia
on Jan 23, 2008 Male patient from UNITED STATES , 53 years of age, was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: asthenia, depression (What is depression?), disorientation, fatigue, nausea (What is nausea?), overdose, paraesthesia. Lariam dosage: 250 Mg Daily.

5765670-4 | Agitation, Ataxia, Confusional State, Deafness, Dizziness, Overdose, Speech Disorder
on Jan 23, 2008 Female patient from UNITED STATES , 82 years of age, was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, ataxia (What is ataxia?), confusional state, deafness, dizziness (What is dizziness?), overdose, speech disorder. Lariam dosage: 250 Mg Daily.

5765665-0 | Abnormal Dreams, Aggression, Anxiety, Depression, Disturbance In Attention, Panic Attack, Suicidal Ideation
Patient was taking Lariam (View Usage). Patient had the following side effects: abnormal dreams, aggression, anxiety (What is anxiety?), depression (What is depression?), disturbance in attention, panic attack, suicidal ideation on Nov 29, 2007 from UNITED STATES Additional patient health information: Male patient , 24 years of age, was diagnosed with malaria prophylaxis and. Lariam dosage: .

5765655-8 | Completed Suicide, Suicidal Ideation, Suicide Attempt
Adverse event was reported on Apr 13, 2007 by a Female patient taking Lariam (View Usage) (Dosage: ) . Location: UNITED STATES , 46 years of age, After Lariam was administered, patient had the following side effects: completed suicide, suicidal ideation, suicide attempt.

5758918-3 | Altered Visual Depth Perception, Balance Disorder, Disturbance In Attention, Dizziness, Herpes Zoster, Memory Impairment
on May 29, 2008 Male patient from GERMANY , weighting 198.4 lb, was diagnosed with prophylaxis, malaria (What is malaria?) and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: altered visual depth perception, balance disorder, disturbance in attention, dizziness (What is dizziness?), herpes zoster, memory impairment. Lariam dosage: .

5758017-0 | Aggression, Insomnia, Weight Decreased
on Jun 02, 2008 Male patient from UNITED STATES , 55 years of age, weighting 150.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: aggression, insomnia, weight decreased. Lariam dosage: 250 Mg Weekly Po.

5757344-0 | Hallucination, Visual, Incoherent, Nightmare, Psychotic Disorder
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: hallucination, visual, incoherent, nightmare, psychotic disorder (What is psychotic disorder?) on May 23, 2008 from SWEDEN Additional patient health information: Female patient , 27 years of age, was diagnosed with malaria prophylaxis and. Lariam dosage: . Patient was hospitalized.

5752217-1 | Cyanosis, Respiratory Distress
Adverse event was reported on May 20, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis and. Location: NETHERLANDS , weighting 11.02 lb, Patient experienced the following unwanted or unexpected effects: cyanosis, respiratory distress. Patient was hospitalized.

5742047-9 | Hallucination, Headache, Nausea, Vertigo
on May 14, 2008 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: hallucination, headache (What is headache?), nausea (What is nausea?), vertigo. Lariam dosage: 1 Pill Once A Week Po. Patient was hospitalized.

5737157-6 | Abdominal Pain, Agitation, Amnesia, Anxiety Disorder, Blood Pressure Increased, Blood Triglycerides Increased, Brain Stem Syndrome, Chest Pain, Deafness
on May 06, 2008 Male patient from UNITED STATES , weighting 242.1 lb, was diagnosed with malaria prophylaxis, enteritis infectious, epididymitis, vestibular disorder and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), agitation, amnesia, anxiety disorder, blood pressure increased, blood triglycerides increased, brain stem syndrome, chest pain (What is chest pain?), deafness. Lariam dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), IMODIUM (View Imodium Review and Imodium Label ), COMPAZINE (View Compazine Review and Compazine Label ), ANTIBIOTICS NOS (View Antibiotics Nos Review and Antibiotics Nos Label ), ANTIVERT (View Antivert Review and Antivert Label ), PREDNISONE TAB (By Taper.) (View Prednisone Tab Review and Prednisone Tab Label ), VALIUM (View Valium Review and Valium Label ).

5735434-6 | International Normalised Ratio Increased
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased on May 05, 2008 from SWEDEN Additional patient health information: Male patient , 69 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Lariam dosage: . During the same period patient was treated with WARFARIN SODIUM (Dosage Regimen Reported As D D) (View Warfarin Sodium Review and Warfarin Sodium Label ).

5731765-4 | Abdominal Pain, Agitation, Amnesia, Anxiety Disorder, Blood Pressure Increased, Blood Triglycerides Increased, Brain Stem Syndrome, Chest Pain, Deafness
Adverse event was reported on Apr 30, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis, enteritis infectious, epididymitis, vestibular disorder and. Location: UNITED STATES , weighting 242.1 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), agitation, amnesia, anxiety disorder, blood pressure increased, blood triglycerides increased, brain stem syndrome, chest pain (What is chest pain?), deafness. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), IMODIUM (View Imodium Review and Imodium Label ), COMPAZINE (View Compazine Review and Compazine Label ), ANTIBIOTICS NOS (View Antibiotics Nos Review and Antibiotics Nos Label ), ANTIVERT (View Antivert Review and Antivert Label ), PREDNISONE TAB (By Taper.) (View Prednisone Tab Review and Prednisone Tab Label ), VALIUM (View Valium Review and Valium Label ).

5730460-5 | Areflexia, Pancreatitis Acute, Pericarditis, Rhabdomyolysis
on Apr 29, 2008 Female patient from FRANCE , 42 years of age, was diagnosed with malaria prophylaxis, anxiety (What is anxiety?) and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: areflexia, pancreatitis acute, pericarditis, rhabdomyolysis. Lariam dosage: . During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

5709774-0 | Abnormal Dreams, Agitation, Anxiety, Asthenia, Cardiovascular Disorder, Coordination Abnormal, Depression, Disturbance In Attention, Dyspepsia
on Apr 08, 2008 Female patient from GERMANY , weighting 149.9 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams, agitation, anxiety (What is anxiety?), asthenia, cardiovascular disorder, coordination abnormal, depression (What is depression?), disturbance in attention, dyspepsia. Lariam dosage: Dosage Regimen Reported As Four Tabs In Total. Weekly Dosage.. Patient was hospitalized.

5702450-X | Neurological Symptom, Psychiatric Symptom
Patient was taking Lariam (View Usage). Patient had the following side effects: neurological symptom, psychiatric symptom on Apr 10, 2008 from UNITED STATES Additional patient health information: Male patient , 30 years of age, weighting 155.0 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: 8 Weekly Buccal.

5694932-4 | Affect Lability, Anxiety, Cardiovascular Disorder, Compulsions, Depression, Heart Rate Irregular, Irritability, Muscle Twitching, Nervous System Disorder
Adverse event was reported on Mar 25, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis and. Location: GERMANY , weighting 165.3 lb, After Lariam was administered, patient had the following side effects: affect lability, anxiety (What is anxiety?), cardiovascular disorder, compulsions, depression (What is depression?), heart rate irregular, irritability, muscle twitching, nervous system disorder.

5693443-X | Agitation, Altered State Of Consciousness, Anxiety, Chest Pain, Claustrophobia, Confusional State, Delusion, Feeling Abnormal, Flight Of Ideas
on Apr 01, 2008 Male patient from UNITED STATES , 58 years of age, weighting 203.3 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, altered state of consciousness, anxiety (What is anxiety?), chest pain (What is chest pain?), claustrophobia, confusional state, delusion, feeling abnormal, flight of ideas. Lariam dosage: 250 Mg Once Weekly Oral. Patient was hospitalized.

5689149-3 | Abnormal Behaviour, Depression, Drowning, Epilepsy, Foot Fracture, Hallucination
on Jul 12, 1994 Male patient from UNITED KINGDOM , 27 years of age, weighting 156.5 lb, was diagnosed with malaria prophylaxis, epilepsy (What is epilepsy?) and was treated with Lariam (View Usage). Patient had the following side effects: abnormal behaviour, depression (What is depression?), drowning (What is drowning?), epilepsy (What is epilepsy?), foot fracture, hallucination. Lariam dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

5688827-X | Mental Disorder
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: mental disorder on Jan 22, 2002 from FRANCE Additional patient health information: Male patient , 68 years of age, weighting 198.4 lb, . Lariam dosage: . During the same period patient was treated with BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ).

5688792-5 | Amyotrophic Lateral Sclerosis
Adverse event was reported on Mar 26, 2008 by a Female patient taking Lariam (View Usage) (Dosage: Dose Reported: 1 Course (common)) was diagnosed with malaria prophylaxis and. Location: GERMANY , 62 years of age, Patient experienced the following unwanted or unexpected effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). Patient was hospitalized.

5685058-4 | Malaise, Nausea
on Aug 28, 1997 Male patient from NETHERLANDS , 67 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: malaise, nausea (What is nausea?). Lariam dosage: .

5685028-6 |
on Feb 03, 1998 Female patient from UNITED KINGDOM , 60 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). . Lariam dosage: . During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ).

5685018-3 | Nasopharyngitis
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: nasopharyngitis on Jul 29, 1997 from SWITZERLAND Additional patient health information: Male patient , 30 years of age, was diagnosed with malaria prophylaxis and. Lariam dosage: . During the same period patient was treated with NEO CITRAN (View Neo-citran Review and Neo-citran Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ).

5676118-2 | Completed Suicide, Hallucination
Adverse event was reported on Mar 10, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis and. Location: GERMANY , 23 years of age, Patient had the following side effects: completed suicide, hallucination. During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ).

5661506-0 | Abdominal Distension, Dyspnoea, Oedema Peripheral
on Mar 03, 2008 Male patient from ITALY , 73 years of age, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: abdominal distension, dyspnoea, oedema peripheral. Lariam dosage: . Patient was hospitalized.

5655523-4 | Cardiovascular Insufficiency, Depression, Suicidal Ideation
on Feb 29, 2008 Male patient from GERMANY , 55 years of age, was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: cardiovascular insufficiency, depression (What is depression?), suicidal ideation. Lariam dosage: . During the same period patient was treated with DOXAM (View Doxam Review and Doxam Label ).

5655519-2 | Liver Function Test Abnormal, Overdose, Somnolence, Suicidal Ideation
Patient was taking Lariam (View Usage). Patient had the following side effects: liver function test abnormal, overdose, somnolence, suicidal ideation on Feb 25, 2008 from GERMANY Additional patient health information: Female patient , 30 years of age, weighting 110.2 lb, was diagnosed with suicidal ideation and. Lariam dosage: . During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), GELONIDA (View Gelonida Review and Gelonida Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TALVOSILEN (View Talvosilen Review and Talvosilen Label ). Patient was hospitalized.

5637331-3 | Cardiovascular Insufficiency, Depression, Suicidal Ideation
Adverse event was reported on Feb 11, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) . Location: GERMANY , 55 years of age, After Lariam was administered, patient had the following side effects: cardiovascular insufficiency, depression (What is depression?), suicidal ideation. During the same period patient was treated with DOXAM (View Doxam Review and Doxam Label ).

5637134-X | Liver Function Test Abnormal, Overdose, Somnolence, Suicidal Ideation
on Feb 11, 2008 Female patient from GERMANY , 30 years of age, was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal, overdose, somnolence, suicidal ideation. Lariam dosage: . During the same period patient was treated with IMODIUM (View Imodium Review and Imodium Label ), GELONIDA (View Gelonida Review and Gelonida Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TALVOSILEN (View Talvosilen Review and Talvosilen Label ).

5636737-6 | Crying, Deafness Unilateral, Suicidal Ideation, Tinnitus
on Feb 19, 2008 Female patient from UNITED STATES , weighting 218.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient had the following side effects: crying, deafness unilateral, suicidal ideation, tinnitus (What is tinnitus?). Lariam dosage: 250 Mg Once Weekly Po (one Dose). During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

5630886-4 | Cerebral Ventricle Dilatation, Foetal Growth Retardation, Premature Baby
Patient was taking Lariam (View Usage). After Lariam was administered, patient had the following side effects: cerebral ventricle dilatation, foetal growth retardation, premature baby on Feb 08, 2008 from SWITZERLAND Additional patient health information: Female patient , weighting 2.87 lb, was diagnosed with malaria prophylaxis, hypothyroidism and. Lariam dosage: . During the same period patient was treated with STILNOX (Reported Frequency 2 Total.) (View Stilnox Review and Stilnox Label ), ELTROXIN (View Eltroxin Review and Eltroxin Label ).

5622046-8 | Abdominal Pain, Agitation, Amnesia, Anxiety Disorder, Blood Pressure Increased, Blood Triglycerides Increased, Brain Stem Syndrome, Chest Pain, Deafness
Adverse event was reported on Jan 31, 2008 by a Male patient taking Lariam (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis, enteritis infectious, epididymitis, vestibular disorder and. Location: UNITED STATES , 35 years of age, weighting 242.1 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), agitation, amnesia, anxiety disorder, blood pressure increased, blood triglycerides increased, brain stem syndrome, chest pain (What is chest pain?), deafness. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), IMODIUM (View Imodium Review and Imodium Label ), COMPAZINE (View Compazine Review and Compazine Label ), ANTIBIOTICS NOS (View Antibiotics Nos Review and Antibiotics Nos Label ), ANTIVERT (View Antivert Review and Antivert Label ), PREDNISONE TAB (By Taper.) (View Prednisone Tab Review and Prednisone Tab Label ), VALIUM (View Valium Review and Valium Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ).

5618791-0 | Depression, Mania, Paranoia
on Jan 29, 2008 Male patient from AUSTRALIA , 22 years of age, was treated with Lariam (View Usage). Patient had the following side effects: depression (What is depression?), mania, paranoia. Lariam dosage: . Patient was hospitalized.

5601165-6 | Anxiety, Insomnia, Mental Disorder, Migraine, Mood Altered, Tinnitus, Visual Disturbance
on Jan 22, 2008 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: anxiety (What is anxiety?), insomnia, mental disorder, migraine (What is migraine?), mood altered, tinnitus (What is tinnitus?), visual disturbance. Lariam dosage: .

5593239-3 | Anxiety, Fear, Mood Swings, Panic Disorder
Patient was taking Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), fear, mood swings, panic disorder (What is panic disorder?) on Jan 15, 2008 from UNITED STATES Additional patient health information: Male patient , 38 years of age, weighting 150.0 lb, was diagnosed with malaria prophylaxis and. Lariam dosage: 1/week Po.

5592903-X | Anxiety, Fear, Feeling Abnormal, Psychotic Disorder
Adverse event was reported on Jan 14, 2008 by a Female patient taking Lariam (View Usage) (Dosage: Once Per Week Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 36 years of age, weighting 150.0 lb, Patient had the following side effects: anxiety (What is anxiety?), fear, feeling abnormal, psychotic disorder (What is psychotic disorder?).

5588505-1 | Amyotrophy, Upper Motor Neurone Lesion
on Jan 02, 2008 Male patient from FRANCE , 61 years of age, was treated with Lariam (View Usage). After Lariam was administered, patient had the following side effects: amyotrophy, upper motor neurone lesion. Lariam dosage: . During the same period patient was treated with ENGERIX B (Form: Inhalation Solution, The Patient Received Three Injections In 1995 (march, April And Septembe+) (View Engerix-b Review and Engerix-b Label ).

5581533-1 | Alcohol Use, Anxiety, Chest Discomfort, Dehydration, Dyspnoea, Fear, Heart Rate Increased, Hyperventilation
on Jan 03, 2008 Female patient from UNITED STATES , 39 years of age, weighting 121.3 lb, was diagnosed with malaria prophylaxis and was treated with Lariam (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol use, anxiety (What is anxiety?), chest discomfort, dehydration, dyspnoea, fear, heart rate increased, hyperventilation. Lariam dosage: 1 Per Week Po. Patient was hospitalized.

5574447-4 | Abnormal Behaviour, Aggression, Agitation, Antinuclear Antibody Positive, Anxiety, Asthenia, Asthma, Attention Deficit/hyperactivity Disorder, Balance Disorder
Patient was taking Lariam (View Usage). Patient had the following side effects: abnormal behaviour, aggression, agitation, antinuclear antibody positive, anxiety (What is anxiety?), asthenia, asthma (What is asthma?), attention deficit/hyperactivity disorder, balance disorder on Dec 21, 2007 from UNITED STATES Additional patient health information: Male patient , 45 years of age, was diagnosed with prophylaxis, malaria prophylaxis and. Lariam dosage: . During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), PRIMAQUINE (View Primaquine Review and Primaquine Label ). Patient was hospitalized and became disabled.